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Abstract 
Purpose: The final decision for discharge from the intensive care unit (ICU) 
is uncertain because it is made according to various patient parameters; however, it 
should be made on an objective evaluation. Previous reports have been inconsistent and 
unreliable in predicting post-ICU mortality. To identify predictive factors associated 
with post-ICU mortality, we analyzed physiological and laboratory data at ICU 
discharge. 
Methods: Patients admitted to our ICU between September 2012 and August 
2013 and staying for critical care >2 days were included. Sequential Organ Failure 
Assessment (SOFA) score; systemic inflammatory response syndrome score; white 
blood cell count; and serum C reactive protein, procalcitonin (PCT), interleukin-6 (IL-6), 
lactate, albumin, and hemoglobin levels were recorded. The primary end point was 
90-day mortality after ICU discharge. Two hundred eighteen patients were enrolled (195 
survivors, 23 non-survivors). 
Results: Non-survivors presented a higher SOFA score and serum PCT, and 
IL-6 levels, as well as lower serum albumin and hemoglobin levels. Serum PCT, 
albumin, and SOFA score were associated with 90-day mortality in multiple logistic 
regression analysis. Hosmer-Lemeshow test showed chi-square value of 6.96, and P 
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value of 0.54. The area under the curve (95% confidence interval) was 0.830 
(0.771-0.890) for PCT, 0.688 (0.566-0.810) for albumin, 0.861 (0.796-0.927) for SOFA 
score, and increased to 0.913 (0.858-0.969) when these were combined. Serum PCT 
level at 0.57 ng/mL, serum albumin at 2.5 g/dL and SOFA score at 5.5 predict 90-day 
mortality, and high PCT, low albumin and high SOFA groups had significantly higher 
mortality. Serum PCT and SOFA score were significantly associated with survival days 
after ICU discharge in Cox regression analysis. 
Conclusions: Serum PCT level and SOFA score at ICU discharge predict 
post-ICU mortality and survival days after ICU discharge. The combination of these two 
and albumin level might enable accurate prediction. 
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Introduction 
 Admission to the intensive care unit (ICU) is considered when patients need 
intensive treatment and monitoring that cannot be provided outside of the ICU [1]. 
Mortality rates of patients admitted to the ICU remain high [2,3], and even if the 
patients survive during the ICU stay and are successfully discharged, these patients 
could have sequelae, including deteriorated cognitive or physical function 
(post-intensive care syndrome) [4] or poor outcomes after the ICU and hospital 
discharge [5-7]. Although institutional and regional characteristics might affect ICU 
discharge criteria, critically ill patients are generally considered suitable for discharge 
from the ICU when their physiological status has stabilized and the need for ICU 
monitoring and care is no longer necessary [1]. In a critical care setting, the basis of the 
final decision for discharge is uncertain, because it is made according to various 
physiological variables and laboratory data. However, the decision should be made on 
an objective evaluation. Persistent inflammation, immunosuppression, malnutrition, and 
catabolism are potentially associated with poor clinical outcome after discharge from 
the ICU [8].  
Serum C reactive protein (CRP) levels at ICU discharge [9,10], maximum 
CRP levels during the ICU stay [10], CRP/albumin ratio at ICU discharge [11], and 
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heart rate at ICU discharge [12] have been reported to be predictive of post-ICU 
mortality. However, results have been inconsistent. Furthermore, these parameters could 
not predict post-ICU mortality accurately. To identify prognostic factors associated with 
90-day mortality after ICU discharge, we prospectively analyzed physiological status 
and laboratory data collected at ICU discharge. 
 
Methods 
 This prospective, observational, follow-up study was performed in the ICU of a 
tertiary-care university hospital in Japan. The hospital has 835 beds, and the 22-bed 
medical-surgical ICU admits 1,600 to 1,800 critically ill patients per year. The ICU has 
24/7 coverage by intensivists, but there is no “Step-down” unit. The ICU team 
comprises intensivists, physicians from various specialty departments, ICU nurses, an 
infection control team (comprising physicians, nurses, and clinical technicians), 
physical therapists (early mobilization, respiratory rehabilitation), clinical engineers 
(medical equipment management, operating blood purification), pharmacists 
(therapeutic drug monitoring and referring drug interactions), and clinical nutritionists 
(planning and evaluation for nutrition) and convenes a daily conference to decide on 
treatment plans.  
  
5 
 
Critically ill patients are treated so as to cure their acute organ failure during 
ICU stay. The ICU team decided to discharge from the ICU when the patient was 
stabilized through acute care and ICU-specific treatments were no longer needed for 
organ failure. Acute organ failure might shift to chronic failure; such as disturbance of 
consciousness or renal failure. ICU team usually decide to discharge the patient from 
the ICU if other organ functions are stable. ICU-specific treatment includes mechanical 
ventilation, intra-aortic balloon pumping, temporary pace-maker, extra-corporeal 
membranous oxygenation, ventricular assist device, renal replacement therapy, 
therapeutic hypothermia. Some artificial supports are performed after ICU discharge; 
ventilator in chronic lung disease or intermittent hemodialysis in chronic kidney disease. 
After considering ICU patient's status, emergency ICU admission of more severe patient, 
and availability of ICU and general ward, attending ICU physician eventually decide 
ICU discharge. 
This study protocol was approved by The Institutional Review Board at Chiba 
University (ethic approval number, 1635), which waived written informed consent 
because of the observational nature of the study. 
Patients 
 Patients admitted to the medical-surgical ICU from September 2012 to August 
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2013 and stayed in critical care >2 days were selected. Patients aged <18 years were 
excluded. The total ICU admission during the study period was 1,723. Seventy-five 
patients (4.4%) died during the ICU stay and 1,648 (95.6%) survived to discharge. A 
total of 247 cases stayed in critical care >2 days. Of these, 23 patients were repeatedly 
admitted to the ICU, and we only included 224 patients’ data from their initial ICU 
admission. Six patients were excluded for age. Thus, 218 patients were enrolled for 
analysis. 
Measurements 
 The following patient characteristics were recorded: age, sex, diagnosis on ICU 
admission, Acute Physiology and Chronic Health Evaluation (APACHE) II score [13], 
Sequential Organ Failure Assessment (SOFA) score [14], readmission cases, surgical 
cases, admission diagnosis, usage of mechanical ventilation, renal replacement therapy 
and vasopressor, antibiotic treatment during the ICU stay and at discharge, infection at 
death, nocturnal discharge (6:00pm to 8:00am), length of ICU stay and in-hospital death. 
Diagnosis on ICU admission was categorized as respiratory failure, renal failure, heart 
failure, disturbance of consciousness, sepsis/infection, post-cardiac arrest, intoxication, 
severe acute pancreatitis, fulminant hepatic failure, trauma, burn, cardiovascular surgery, 
other elective surgery, or miscellaneous. 
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 We recorded physiological and laboratory data at ICU discharge as follows: 
SOFA score, systemic inflammatory response syndrome (SIRS) score [15], white blood 
cell (WBC) count, serum CRP level, PCT level, blood interleukin-6 (IL-6) level, blood 
lactate level, serum albumin level, and hemoglobin level. Serum CRP, PCT, and blood 
IL-6 were ordered after the decision to discharge the ICU patient was made if it had not 
already been done for clinical reasons. WBC (measurable range, 0.0–10×106/μL; normal 
range, 4.0-9.0×10
3/μL) and hemoglobin (measurable range, 0.0–30 g/dL; normal range, 
14.0–17.0 [male], 12.0-16.0 [female] g/dL) was measured with an automated 
hematology system (Sysmex XE-2100; Sysmex Corporation, Kobe, Japan). Serum CRP 
(measurable range, 0.1–20 mg/dL; normal range <0.2 mg/dL) and albumin (measurable 
range, 0.1–10 g/dL; normal range, 3.9–5.1 g/dL) were measured with a BioMajesty 
JCA-BM 8040 automated analyzer (JEOL, Tokyo, Japan) using a CRP-Latex (Ii)X2 
assay kit (Denka Seiken Co., Ltd., Tokyo, Japan) and a BCG method (ALB･S, Sysmex 
Corporation, Kobe, Japan), respectively. Serum PCT (measurable range, 0.02–100 
ng/mL; normal range, <0.25 ng/dL) and IL-6 (measurable range, 1.5–5000 pg/mL; 
normal range, <4 pg/mL) were measured with a chemistry analyzer (Cobas e411, Roche 
Diagnostics GmbH, Mannheim, Germany). Lactate (measurable range, 0.1–20 mmol/L; 
normal range, <1.3 mmol/L) was measured with a blood gas analyzer (GEM 
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PremierTM 4000, IL Japan, Tokyo, Japan). When the measurements were out of range, 
diluted samples were used for analysis.  
 The primary end point was 90-day mortality after ICU discharge; this was 
assessed using medical records or through written questionnaires for family members, 
as was the length of survival and antibiotic use at the time of discharge. Enrolled 
patients were divided into two groups according to death by 90 day after ICU discharge; 
survivor group and non-survivor group. 
Statistical Analysis 
 Data are presented as median (25th–75th percentile), absolute numbers, and 
percentages. We tested for between-group differences using Fisher’s exact test for 
categorical data and Mann-Whitney’s U test for continuous data. 
 To extract factors affecting 90-day mortality, we performed binary logistic 
regression analysis (stepwise method) using death by 90 day after ICU discharge as a 
dependent variable. We selected followings as independent variables; age, sex, 
physiological or laboratory data at ICU discharge that have significant differences 
between the two groups in Mann-Whitney’s U test. Goodness of fit of the model was 
assessed by the Hosmer-Lemeshow test and calibration plot. Receiver operating 
characteristic (ROC) analysis was performed among independent variables associated 
  
9 
 
with 90-day mortality after ICU discharge in binary logistic regression analysis, setting 
the cutoff point to the highest Youden index (sensitivity [%] + specificity [%]  100) 
[16]. We also performed a log-rank test of the Kaplan-Meier survival curve derived 
from the cutoff point of PCT level and SOFA score at ICU discharge and Cox 
regression analysis (stepwise method) for independent variables associated with 90-day 
mortality after ICU discharge in binary logistic regression analysis, using survival days 
after ICU discharge as a survival variable. IL-6 level and PCT level were analyzed by 
logarithmic transformation. The statistical analysis was performed using SPSS version 
22 (IBM Corporation, Chicago, IL) software. Differences were considered significant at 
P < 0.05 (two-tailed).  
 
Results 
 There were 195 (89.4%) patients in the survivor group, and 23 (10.6%) in the 
non-survivor group. No significant differences were found for age, and the proportion of 
male sex was higher in the non-survivor group (Table 1). Non-survivors had 
significantly higher APACHE II and SOFA scores on ICU admission compared to 
survivors (P < 0.001). There was no difference in antibiotic treatment between survivors 
and non-survivors (Table 1). 
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 Physiological status and laboratory data at ICU discharge were compared 
between the survivor and non-survivor groups (Table 2). Non-survivors had a higher 
SOFA score (P < 0.001) and serum PCT and IL-6 levels (P < 0.001) and decreased 
serum albumin (P = 0.003) and hemoglobin levels (P = 0.004) at ICU discharge 
compared to survivors.  
To determine factors associated with 90-day mortality after ICU discharge, 
binary logistic regression analysis was carried out using age, sex, PCT level, IL-6 level, 
albumin level, hemoglobin level, and SOFA score as independent variables. Serum PCT 
level, albumin level, and SOFA score at ICU discharge were significantly associated 
with altered 90-day mortality after ICU discharge (Table 3). Hosmer-Lemeshow test 
showed chi-square value of 6.96, and P value of 0.54. Calibration plot showed the 
observed versus the predicted mortality after ICU discharge (Figure S1). 
 We performed a ROC analysis to determine the predictive level of serum PCT, 
albumin level, and SOFA score at ICU discharge for 90-day mortality after ICU 
discharge. The cutoff value to achieve the highest Youden index was 0.57 ng/mL for 
PCT (sensitivity, 95.7%; specificity, 69.7%), 2.5 g/dL for albumin level (sensitivity, 
60.9%; specificity, 76.4%), and 6 for SOFA score (sensitivity, 91.3%; specificity, 
65.6%). The area under the curve (AUC) for each factor was 0.830 (95% confidence 
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interval [CI], 0.771–0.890) for PCT, 0.688 (0.566–0.810) for albumin, and 0.861 
(0.796–0.927) for SOFA score, respectively (Figure 1). The AUC for the combination 
of PCT level, SOFA score, and albumin level increased to 0.913 (0.858–0.969). Groups 
with high SOFA, high PCT, or low albumin had a significantly higher 90-day mortality 
rate after ICU discharge in Kaplan-Meier survival analysis (log-rank test) (Figure 2). 
We also performed Cox regression analysis using serum PCT, albumin level, and SOFA 
score at ICU discharge as independent variables, survival days after ICU discharge as 
survival variable. Serum PCT and SOFA score were significantly associated with 
survival days after ICU discharge (Table 4). 
 
Discussion 
 This study was conducted to identify prognostic factors associated with 90-day 
mortality after ICU discharge. The results indicate that non-survivors present a higher 
SOFA score, higher serum PCT and IL-6 levels, and lower serum albumin and 
hemoglobin levels at ICU discharge compared to survivors. Subsequent logistic 
regression analysis showed that serum PCT level, albumin level, and SOFA score at 
ICU discharge were associated with 90-day mortality after ICU discharge. While 
individual AUC for SOFA score, PCT level, and albumin level presented high 
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diagnostic accuracy, the accuracy increased when these factors were combined; this 
could be useful for decisions regarding ICU discharge. 
 Serum CRP level at ICU discharge [9,10], a reduction of CRP level >25% in 
the last 24 hours before ICU discharge [17], CRP/albumin ratio [11], and heart rate at 
ICU discharge [12] have been reported as useful predictive markers or indicators of 
long-term outcome. On the other hand, reports have indicated that CRP levels at ICU 
discharge were not a predictor of hospital mortality [18,19]. In the present study, CRP 
level; any SIRS criterion, including heart rate; or the total SIRS score were not 
predictive of mortality after ICU discharge (Table 2). This might be because CRP and 
SIRS subscores are markers that may be elevated in inflammation without infection. 
Blood PCT level shows a significant rise in cases of bacterial infections but is 
suppressed by interferon- in cases of viral infections. This characteristic elevates the 
sensitivity for bacterial infections [20-22]. PCT has also been known to resist 
suppression by administration of steroids [23] compared with other biomarkers. Owing 
to these characteristics, elevated PCT level at ICU admission has been reported as a 
good diagnostic marker for patients with suspected sepsis [24,25]. Thus, PCT has better 
diagnostic accuracy for sepsis than CRP or IL-6 [24,26]. Although its diagnostic value 
for acute infection is not as high as IL-6, PCT is expected to be a highly specific marker 
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for chronic and persistent infection occurring in late phase sepsis [27]. There was a 
report on the predictive value of a PCT decrease in first 72 hours in the ICU for hospital 
mortality [28], but the present study is the first to report that PCT at discharge predicts 
post-ICU mortality. This study analyzed physiological status and laboratory data at ICU 
discharge, which is simpler than maximum value or sequential measurement of a certain 
biomarker during the ICU stay, and is more applicable to the clinical setting. Patients 
without sepsis or infection on ICU admission may also be treated with antibiotics 
because of complicated or nosocomial infection. Therefore, no significant differences 
were observed in the proportion of antibiotics treatment during ICU stay between 
survivors and non-survivors. However, incidence of infection at death in non-survivors 
was 60.9%, which is the same as the proportion of antibiotics treatment at ICU 
discharge. It can be speculated that PCT level reflected persistent infection, even when 
no significant differences were seen in the proportion of antibiotics treatment at ICU 
discharge between survivors and non-survivors. 
The SOFA score indicates organ dysfunction and is widely used as a severity 
measure for critically ill patients. Persistent organ dysfunction might affect post-ICU 
mortality. Previous studies showed that SOFA score on ICU admission or maximum 
SOFA score during the ICU stay was predictive of ICU or hospital mortality [29,30], but 
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no study has reported an association of SOFA score at discharge and post-ICU mortality. 
This is the original perspective of the present study. 
Serum albumin levels are widely used to assess the general nutritional status 
of patients [31]. Low serum albumin levels have been reported to be associated with 
post-ICU mortality [18,32]. The present results showed that low serum albumin is an 
independent risk factor for 90-day mortality after ICU discharge. Persistent 
inflammation may have led to malnutrition of the study patients [33]. 
  In the present study, serum PCT level (AUC, 0.830) and SOFA score (AUC, 
0.861) accurately predicted 90-day mortality after ICU discharge. Each parameter itself 
had accurate diagnostic ability. Furthermore, combining PCT and albumin levels with 
SOFA score elevated the AUC to as high as 0.913 (95% CI, 0.858–0.945).  However, 
when patients fall into unresolvable coma or renal failure, the SOFA score is persistently 
elevated, making it inappropriate as an indicator for deciding discharge from the ICU.  
Moreover, SOFA score does not include parameters of infection or malnutrition, 
diagnostic accuracy for post-ICU mortality was improved when combining SOFA score 
with serum PCT level (an indicator of infection) and serum albumin level (an indicator 
of malnutrition). These parameters can be appropriate criteria for ICU discharge. 
 Some patients discharge from the ICU even though they do not fulfill the 
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criteria above. We could not evaluate the efficacy of "step-down” unit because our 
hospital does not have it. However, it will certainly play important roles in such 
patients. 
 This study has several limitations. First, it was a single-center observational 
study, so ICU physician and ward physician were not blinded to the study blood test. 
Treatment of the patients may have been changed by the results of the laboratory 
examination. Especially, albumin and hemoglobin levels can be elevated by replacement 
or transfusion therapy. This may have resulted in treatment bias. Second, because 
mortality after ICU discharge was very low, the results may not be applicable to centers 
with higher mortality rates. Third, some non-survivors died other hospital and we did 
not collected post-mortem data. We could not assess the post ICU death were 
preventable or not. 
 
Conclusions 
 Non-survivors presented a higher SOFA score and serum PCT and IL-6 levels, 
as well as lower serum albumin and hemoglobin levels at ICU discharge. Serum PCT 
level, albumin level, and SOFA score at ICU discharge were independently associated 
with 90-day mortality after ICU discharge. High serum PCT level (≧0.57 ng/mL) and 
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SOFA score (≧6) predict post-ICU mortality and survival days after ICU discharge, and 
the combination of these two parameters with albumin level might enable accurate 
prediction of post-ICU mortality. 
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Figure Legends 
Figure 1. Receiver operating characteristic analysis of SOFA score, serum PCT, 
and albumin level at ICU discharge and 90-day mortality.  The area under the 
curve (95% confidence interval) was 0.830 (0.771-0.890) for PCT, 0.688 (0.566-0.810) 
for albumin (inverse), and 0.861 (0.796-0.927) for SOFA score. The AUC for these 
three indicators combined was elevated to 0.913 (0.858-0.969). 
ICU, intensive care unit; IL-6, interleukin-6; PCT, procalcitonin; SOFA, Sequential 
Organ Failure Assessment. 
 
Figure 2. Kaplan-Meier survival curve for 90 days after ICU discharge in high and 
low groups divided by SOFA, PCT, and albumin. 
(a) High SOFA vs. Low SOFA group 
(b) High PCT vs. Low PCT group 
(c) Low albumin vs. High albumin group 
The graph shows curves for the two groups (high SOFA vs. low SOFA, high PCT vs. 
low PCT, and low albumin vs. high albumin) derived from the cutoff value for SOFA 
score at 6 (P < 0.001), PCT level at 0.57 ng/mL (P < 0.001), and albumin level at 2.5 
g/dL (P = 0.001) at ICU discharge (log-rank test). 
ICU, intensive care unit; PCT, procalcitonin; SOFA, Sequential Organ Failure 
Assessment 
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Supporting Information Legends 
Figure S1. Calibration plot showing the observed probability versus the predicted 
mortality.  Goodness of fit of the model was assessed by the Hosmer-Lemeshow test; 
chi-square value of 6.96, P value of 0.54. The diagonal line indicates perfect calibration 
(predicted mortality equal observed mortality). 
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Tables 
Table 1. Baseline characteristics and ICU treatment 
 Survivors 
(n = 195) 
Non-survivors 
(n = 23) 
P value 
Age, years 68 (54–75) 70 (63–80) 0.12 
Male sex 128 (65.6) 20 (87.0) 0.056 
APACHE
a
 II score on ICU
b
 Admission 22.0 (16.0–29.0) 33.0 (25.5–38.0) <0.001 
Predicted hospital mortality 33.3 (18.0-67.2) 74.0 (51.4-88.3) <0.001 
SOFA
c
 score on ICU admission 7.0 (4.0–10.0) 12 (10–15.5) <0.001 
ICU readmission cases 19 (9.7) 4 (17.3) 0.28 
Surgical cases 84 (43.1) 4 (17.4) 0.023 
Admission diagnosis    
Sepsis/infection 41 (21.0) 8 (34.8)  
Cardiovascular surgery 53 (27.2) 1 (4.3)  
Post-cardiac arrest 11 (5.6) 2 (8.7)  
Intoxication 1 (0.5) 1 (4.3)  
SAP
d
/FHF
e
 6 (3.1) 0 (0)  
Trauma/burn 22 (11.3) 2 (8.7)  
Respiratory failure 18 (9.2) 3 (13.0)  
Renal failure 4 (2.1) 2 (8.7)  
Heart failure 5 (2.6) 0 (0)  
Disturbance of consciousness 6 (3.1) 1 (4.3)  
Miscellaneous 28 (14.4) 3 (13.0)  
Mechanical ventilation 139 (71.3 20 (87.0) 0.14 
Renal replacement therapy 49 (25.1) 12 (52.2) 0.012 
Vasopressor 85 (43.6) 13 (56.5 0.27 
Antibiotics treatment    
During ICU stay 169 (86.7) 19 (78.2) 0.34 
At ICU discharge 136 (69.7) 14 (60.9) 0.48 
Infection at death - 14 (60.9)  
Nocturnal ICU discharge 6 (3.1) 1 (4.3) 0.55 
ICU length of stay, days  6.0 (4.0–11) 7.0 (4.5–14) 0.15 
Inhospital death by 90 day after ICU discharge  17 (73.9)  
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Data are medians (25th–75th percentile), n (%), and absolute numbers. P values were 
calculated by Mann-Whitney U test or Fisher exact test. Predicted hospital mortality 
were calculated from APACHE II score. 
a
APACHE, Acute Physiology and Chronic Health Evaluation score; 
b
ICU, intensive care 
unit; 
c
SOFA, Sequential Organ Failure Assessment score; 
d
SAP, severe acute 
pancreatitis; 
e
FHF, fulminant hepatic failure. 
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Table 2. Comparison of physiological and laboratory data at ICU discharge between 
survivors and non-survivors 
 
Finding at ICU
a
 discharge 
Survivors 
(n = 195) 
Non-survivors 
(n = 23) 
P value 
SOFA
b
 score 4.0 (3.0–6.0) 8.0 (7.0–10) <0.001 
(a) Respiratory system 1.0 (0–2.0) 2.0 (0–2.0) 0.53 
(b) Coagulation 0 (0–2.0) 1 (0–3.0) 0.14 
(c) Liver 0 (0–1.0) 2.0 (0–3) <0.001 
(d) Cardiovascular 0 (0–0) 0 (0–0) 0.022 
(e) Central nervous system 1.0 (0–2.0) 2.0 (1.0–4.0) 0.001 
(f) Renal 0 (0–1.0) 0 (0–3.0) 0.046 
SIRS
c
 score 2 (1–3) 2 (2–3) 0.070 
(a) BT
d
 (<36°C, >38°C) 38 (19.5) 5 (21.7) 0.78 
(b) HR
e
 (>90/min)  107 (54.9) 16 (69.6) 0.19 
(c) RR
f
 (>20/min) 168 (86.2) 21 (91.3) 0.75 
(d) WBC
g
 (<4,000, >12,000/μL) 78 (40.0) 13 (56.5) 0.179 
Laboratory data    
WBC, 10
3
/L 10.3 (7.5–13.5) 9.2 (5.1–12.6) 0.34 
CRP
h
, mg/dL 4.9 (2.2–10.9) 6.8 (3.0–12.1) 0.30 
PCT
i
, ng/mL 0.25 (0.12–0.79) 1.23 (0.67–3.21) <0.001 
IL-6
j
, pg/mL 27 (15–59) 70 (33–247) <0.001 
Lactate, mmol/L 0.9 (0.7–1.3) 1.1 (0.9–1.4) 0.065 
Albumin, g/dL 2.8 (2.5–3.2) 2.4 (2.1–2.8) 0.003 
Hemoglobin, g/dL 9.9 (8.8–11.1) 8.6 (7.9–9.8) 0.004 
Data are median (25th-75th percentile), n (%). P values were calculated by 
Mann-Whitney U test or Fisher exact test.  
a
ICU, intensive care unit; 
b
SOFA, Sequential Organ Failure Assessment; 
c
SIRS, 
systemic inflammatory response syndrome; 
d
BT, body temperature; 
e
HR, heart rate; 
f
RR, 
respiratory rate.
g
WBC, white blood cell count; 
h
CRP, C-reactive protein; 
i
PCT, 
procalcitonin; 
j
IL-6, interleukin-6 
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Table 3. Variables for multiple logistic regression analysis to predict 90-day mortality 
after ICU discharge 
 
 OR
a
 95% CI
b
 P value 
PCT
c
 6.47 2.22–18.9 0.001 
Albumin 0.23 0.073–0.725 0.012 
SOFA
d
 score 1.60 1.29–1.98 <0.001 
Odds ratio associated 1 unit change in each parameter. Hosmer-Lemeshow test showed 
chi-square value of 6.96, and P value of 0.54. 
a
OR, odds ratio; 
b
CI, confidence interval; 
c
PCT, procalcitonin; 
d
SOFA, 
e
Sequential 
Organ Failure Assessment 
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Table 4. Variables for Cox regression analysis associated with survival days after ICU 
discharge 
 
 HR
a
 95% CI
b
 P value 
PCT
c
 3.87 2.20-8.81 <0.001 
SOFA
d
 score 1.22 1.11-1.24 <0.001 
Hazard ratio associated 1 unit change in each parameter. 
a
HR, hazard ratio; 
b
CI, confidence interval; 
c
PCT, procalcitonin; 
d
SOFA, 
e
Sequential 
Organ Failure Assessment 
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